
Department of Commerce Announces Section 232 Pharmaceutical Investigation
The Trump Administration issued a notice on Monday titled, “Notice of Request for Public Comments on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients,” which could serve as a precursor to imposing …